Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Antikörperseroprävalenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem österreichischen Schlüsselkollektiv an Arbeitnehmer*Innen

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04354779
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:00.665681+00:00
Published At
2020-09-30T00:00:00+00:00
Record Updated At
2020-09-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Severe Acute Respiratory Syndrome Coronavirus 2", "SARS-CoV 2", "Coronavirus Infection", "Covid19"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-30"
protocolSection.identificationModule.nctId
"NCT04354779"
protocolSection.identificationModule.officialTitle
"Antik\u00f6rperseropr\u00e4valenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem \u00f6sterreichischen Schl\u00fcsselkollektiv an Arbeitnehmer*Innen"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Severe Acute Respiratory Syndrome Coronavirus 2 (protocolSection.conditionsModule.conditions)
  • SARS-CoV 2 (protocolSection.conditionsModule.conditions)
  • Coronavirus Infection (protocolSection.conditionsModule.conditions)
  • Covid19 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.